Clinical trial / 2011
Daily rooibos tea consumption improved lipid peroxidation markers, redox status, and lipid profiles in adults at risk for cardiovascular disease.
After a 2-week washout, 40 adults consumed six cups of fermented rooibos daily for 6 weeks, followed by a control period. Rooibos consumption significantly increased plasma total polyphenols (79.8±16.9 to 89.8±14.1 mg/L), reduced glutathione (797±238 to 1082±140 μmol/L), GSH:GSSG ratio (41±14 to 76±17), and HDL-cholesterol (0.9±0.1 to 1.2±0.2 mmol/L). It also significantly decreased conjugated dienes (167.3±29.5 to 108.8±20.1 nmol/mL), TBARS (1.9±0.6 to 0.9±0.3 μmol/L), LDL-cholesterol (4.6±1.3 to 3.9±0.7 mmol/L), and triacylglycerols (1.7±0.8 to 1.2±0.7 mmol/L), while plasma antioxidant capacity remained unchanged.
- Study type
- Controlled clinical trial
- Who was studied
- 40 adults at risk for cardiovascular disease
- What was measured
- Antioxidant capacity, lipid peroxidation, redox status, and lipid profile
THE PAPER
Effects of rooibos (Aspalathus linearis) on oxidative stress and biochemical parameters in adults at risk for cardiovascular disease.
Marnewick JL, Rautenbach F, Venter I, Neethling H, Blackhurst DM, Wolmarans P, Macharia M. J Ethnopharmacol, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.